Nvidia stock gains on China H200 chip order report — what moves NVDA next
23 January 2026
1 min read

Nvidia stock gains on China H200 chip order report — what moves NVDA next

New York, January 23, 2026, 16:02 (EST) — After-hours

Nvidia (NVDA) shares climbed roughly 1.5% in regular trading Friday, closing at $187.53. Bloomberg News reported that Chinese regulators have instructed Alibaba and other major tech companies to start preparing orders for Nvidia’s H200 AI chips. 1

Why this matters now: investors are grappling with just how much Nvidia’s AI-chip sales can keep flowing into China before another sudden policy shift hits. Earlier this month, the U.S. Commerce Department’s Bureau of Industry and Security announced it would scrutinize export license requests for the H200 and comparable chips individually, tightening security measures. 2

Washington has officially approved China-bound sales of the H200, but under strict conditions like third-party testing and restrictions linked to U.S. customer supply, Reuters reported. Jay Goldberg, an equities analyst at Seaport Research, described the export rules as “a Band-Aid” and cautioned that enforcing them might be tricky. 3

Chinese regulators have given “in-principle” green lights to Alibaba, Tencent, and ByteDance, allowing them to proceed with the next steps in their purchase plans, according to sources cited by Bloomberg. Beijing is expected to push these companies to buy a portion of domestic chips as part of the approval process, although the exact quota remains unspecified. 4

Nvidia’s shares fluctuated from $186.82 to $189.60 on Friday, opening at $187.49, per Yahoo Finance data. 5

The broader market showed volatility. The S&P 500 closed unchanged at 6,915.16, while the Nasdaq inched up 0.27% to 23,498.53. The Dow dropped 0.58%, dragged down by Intel’s disappointing outlook, Reuters reported. Next week, all eyes will be on the Federal Reserve’s decision and a packed slate of tech earnings. 6

Chip peers showed a sharp divide. AMD climbed roughly 2.1%, but Intel dropped around 17.3%, highlighting how fast sentiment shifts on data-center demand and supply news.

China’s position keeps shifting. Suppliers for Nvidia halted production of certain H200 parts after Chinese customs stopped earlier shipments, a report revealed, fueling investor concerns over supply chain snags beyond just U.S. export controls. 7

But Beijing’s nod isn’t a guaranteed go-ahead. Investors must still weigh the risk of abrupt regulatory shifts on both sides of the Pacific. Reuters reported last week that Chinese customs officials were instructed to block H200 chips from entering China, underscoring the uncertainty as local competitors ramp up their own AI processors. 8

Traders are now turning their attention to potential formal approvals in China, as well as Nvidia’s upcoming earnings report. The chipmaker is set to release its fiscal 2026 fourth-quarter results on Feb. 25. 9

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Why IREN stock price is jumping today: Feb. 5 earnings set, 2x short ETF launches
Previous Story

Why IREN stock price is jumping today: Feb. 5 earnings set, 2x short ETF launches

Microsoft stock price jumps nearly 4% — what Wall Street is watching before next week’s earnings
Next Story

Microsoft stock price jumps nearly 4% — what Wall Street is watching before next week’s earnings

Go toTop